Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Johnson and Johnson
Baxter
Medtronic
AstraZeneca

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

ESKATA Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Eskata, and what generic alternatives are available?

Eskata is a drug marketed by Aclaris and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-six patent family members in fifteen countries.

The generic ingredient in ESKATA is hydrogen peroxide. There are fifty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrogen peroxide profile page.

Summary for ESKATA
International Patents:26
US Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 103
Patent Applications: 5,031
Formulation / Manufacturing:see details
DailyMed Link:ESKATA at DailyMed
Drug patent expirations by year for ESKATA
Generic Entry Opportunity Date for ESKATA
Generic Entry Date for ESKATA*:
Constraining patent/regulatory exclusivity:
NEW PRODUCT
NDA:
Dosage:
SOLUTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for ESKATA
[OH(OH)]
218625-72-0
30 %Hydrogen peroxide(aq)
37355-84-3
66554-50-5
7722-84-1
8007-30-5
97929-73-2
AC1L1A0N
Accel Concentrate
ACMC-20akqy
Adeka Super EL
AKOS015856794
Albone
Albone 35
Albone 35CG
Albone 50
Albone 50CG
Albone 70
Albone 70CG
Albone DS
Anti-Keim 50
Asepticper
Astri-UC
Baquashock
BBX060AN9V
bis(hydridooxygen)(O--O)
C00027
Caswell No. 486AAA
CCRIS 1060
CHEBI:16240
CHEMBL71595
CIX
Clarigel Gold
Crestal Whitestrips
Crystacide
CTK2H7501
D00008
DB11091
Dentasept
Deslime LP
Dihydrogen dioxide
dihydrogen peroxide
dihydrogen(peroxide)
dioxidane
DTXSID2020715
EC 231-765-0
EINECS 231-765-0
Elawox
EPA Pesticide Chemical Code 000595
FT-0627133
H2O2
High Test Peroxide
Hioxy
Hioxyl
Hipox
HOOH
HSDB 547
HTP [peroxide]
Hybrite
Hydrogen dioxide
Hydrogen dioxide solution
hydrogen hydroperoxide
hydrogen per oxide
hydrogen peroxide
Hydrogen peroxide (> 52% conc.)
Hydrogen peroxide (8CI)
Hydrogen peroxide (conc > 52%)
Hydrogen peroxide (conc >52%)
Hydrogen peroxide (H2O2)
Hydrogen peroxide (H2O2) (9CI)
Hydrogen peroxide (USP)
Hydrogen Peroxide [Topical Solution]
Hydrogen peroxide [USP]
Hydrogen peroxide 15%
Hydrogen peroxide 35%
Hydrogen peroxide 50%
Hydrogen peroxide solution
Hydrogen peroxide solution (DOT)
Hydrogen peroxide solution, >=30%, for trace analysis
Hydrogen peroxide solution, 3%, for microbiology
Hydrogen peroxide solution, 30 % (w/w) in H2O, contains stabilizer
Hydrogen Peroxide Solution, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Hydrogen peroxide solution, 50 wt. % in H2O, stabilized
Hydrogen peroxide solution, AR, contains sodium pyrophosphate as stabilizer, >=30 % (w/v)
Hydrogen peroxide solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Hydrogen peroxide solution, contains inhibitor, 30 wt. % in H2O, ACS reagent
Hydrogen peroxide solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Hydrogen peroxide solution, contains inhibitor, 35 wt. % in H2O
Hydrogen peroxide solution, contains potassium stannate as inhibitor, 30-32 wt. % in water, semiconductor grade, 99.999% trace metals basis
Hydrogen peroxide solution, extra pure, 30.0-32.0%
Hydrogen peroxide solution, for ultratrace analysis
Hydrogen peroxide solution, JIS special grade, 30.0-35.5%
Hydrogen peroxide solution, LR, contains sodium pyrophosphate as stabilizer, >=30 % (w/v)
Hydrogen peroxide solution, LR, contains sodium pyrophosphate as stabilizer, >=50 % (w/v)
Hydrogen peroxide solution, meets analytical specification of Ph. Nord., 34.5-36.5%
Hydrogen peroxide solution, p.a., ACS reagent, reag. ISO, 30.0%
Hydrogen peroxide solution, puriss. p.a., ACS reagent, not stabilized, >=30% (RT)
Hydrogen peroxide solution, purum p.a., >=30% (RT)
Hydrogen peroxide solution, purum p.a., >=35% (RT)
Hydrogen peroxide solution, SAJ first grade, >=30.0%
Hydrogen peroxide solution, semiconductor grade MOS PURANAL(TM) (Honeywell 17937), >=30%
Hydrogen peroxide solution, semiconductor grade PURANAL(TM) (Honeywell 17948), >=30%
Hydrogen peroxide solution, semiconductor grade ULSI PURANAL(TM) (Honeywell 17024), >=30%
Hydrogen peroxide solution, semiconductor grade VLSI PURANAL(TM) (Honeywell 17606), >=30%
Hydrogen peroxide solution, tested according to Ph.Eur.
Hydrogen peroxide solutions
Hydrogen peroxide solutions (over 60% but not over 70%)
Hydrogen peroxide solutions (over 8% but not over 60%)
Hydrogen peroxide, 20% to 60%
Hydrogen peroxide, 3 wt.% solution in water, stabilized
Hydrogen peroxide, 3%
Hydrogen peroxide, 30%
Hydrogen Peroxide, 50%
Hydrogen peroxide, 6% in water
Hydrogen peroxide, 8% to 20%
Hydrogen peroxide, 90%
HYDROGEN PEROXIDE, ACS
Hydrogen peroxide, ACS reagent, 30 wt% solution in water, nonstabilized
Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary)
Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]
Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]
Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary)
Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]
Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]
Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary)
Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) [UN2984] [Oxidizer]
Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) [UN2984] [Oxidizer]
Hydrogen peroxide, pure, 50 wt% solution in water, stabilized
Hydrogen peroxide, solution
Hydrogen peroxide, solution 30%
Hydrogen peroxide, solution, 3%
Hydrogen peroxide, solution, 30%
Hydrogen peroxide, solution, 35%
Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide
Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide [UN2015] [Oxidizer]
Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide [UN2015] [Oxidizer]
Hydrogen peroxide, technical, 35 wt% solution in water, stabilized
HYDROGEN-PEROXIDE
hydrogenperoxide
hydroperoxide
I14-62939
Inhibine
Interox
Kastone
Lase Peroxide
Lensan A
Lensept
LS-2428
Magic Bleaching
Metrokur
MFCD00011333
MHAJPDPJQMAIIY-UHFFFAOYSA-N
Mirasept
MolMap_000025
MolPort-003-927-052
Nite White Excel 2
NSC 19892
NSC-19892
NSC19892
O-O
Odosat D
Opalescence Xtra
Oxigenal
oxydol
Oxydol (JP17)
Oxyfull
Oxyfull (TN)
Oxysept
Oxysept I
Pegasyl
PEO
perhydrol
Perone
Perone 30
Perone 30 Perone 35
Perone 35
Perone 50
Perossido di idrogeno
Perossido di idrogeno [Italian]
Peroxaan
Peroxan
Peroxclean
Peroxide
Peroxide Ion
Peroxyde d'hydrogene
Peroxyde d'hydrogene [French]
Pre milk HP 0.5
Pre milk HP 0.5 10
Pre milk HP 1.0
Puresept
QTL1_000041
Quasar Brite
RL04954
Select Bleach
Superoxol
T-Stuff
Teat dip HP 5
TR-037767
UN 2014 (20%-52%)
UN 2015 (>52%)
UN 2984 (8%-20%)
UN2014
UN2015
UN2984
UNII-BBX060AN9V
UNL-UNL
Wasserstoffperoxid
Wasserstoffperoxid [German]
Waterstofperoxyde
Waterstofperoxyde [Dutch]
Whiteness HP
Whitespeed
WLN: H2 O2 90%
Xtra White

US Patents and Regulatory Information for ESKATA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for ESKATA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2787345 CR 2016 00055 Denmark   Start Trial PRODUCT NAME: MIGALASTAT ELLER ET SALT HERAF, HERUNDER HYDROGENKLORIDSALTET; REG. NO/DATE: EU/1/15/1082 20160531
0281459 SPC/GB99/001 United Kingdom   Start Trial PRODUCT NAME: CLOPIDOGREL HYDROGEN SULPHATE, THE DEXTROROTATORY ISOMER OF ALPHA-(4,5,6,7-TETRAHYDROTHIENO(3,2-C)PYRID-5-YL)(2-CHLOROPHENYL) METHYL ACETATE AS THE HYDROGEN SULPHATE SALT; REGISTERED: UK EU/1/98/069/001 19980715; UK EU/1/98/069/002 19980715; UK EU/1/98/069/003 19980715
2787345 CA 2016 00055 Denmark   Start Trial PRODUCT NAME: MIGALASTAT ELLER ET SALT HERAF, HERUNDER HYDROGENKLORIDSALTET; REG. NO/DATE: EU/1/15/1082 20160531
0281459 98C0036 France   Start Trial PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001
0302769 98C0036 Belgium   Start Trial PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001
0605697 SPC/GB01/008 United Kingdom   Start Trial PRODUCT NAME: 1-(((3-(2-(DIMETHYLAMINO)ETHYL)INDOL-5-YL)METHYL)SULFONYL)PYRROLIDINE GENERIC NAME ALMOTRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY AS ALMOTRIPTAN D,L - HYDROGEN MALATE; REGISTERED: ES 62.877 19991223; UK PL 16973/0005 20001026
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Colorcon
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.